Gene Editing: The Future of Genomic Medicine & Biotech Investing
Goldman Sachs Exchanges · 18 minutes ·

Gene Editing: The Future of Genomic Medicine & Biotech Investing

In the latest episode of Exchanges at Goldman Sachs, Salveen Richter, Lead Analyst for the U.S. Biotechnology Sector in Goldman Sachs Research, explains how new innovations in gene editing are transforming the future of medicine and the greater biotech investment landscape. 

Comments (0)

You Must Be Logged In To Comment

Similar podcasts

Business Of Biotech

The Future of Medicine Podcast

The Future Of Fashion Business

Business and Investing

The Video Editing Podcast

The Editing Bay

The Editing Podcast

The Editing Podcast